Viral expression vectors
CA 2373026 C · Owner: Kbp Acquisition, Inc. · Inventors: Lindbo, John A.; Pogue, Gregory P.; Fitzmaurice, Wayne P.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides nucleic acid sequences having an altered viral movement protein and 126/183kDa replicase proteins further characterized in its ability to stabilize a transgene contained in a virus that expresses the altered movement protein. The present invention also provides viral vectors expressing the altered movement protein cells transformed with the vectors, and host plants infected by the viral vectors.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 4, 2000 and granted May 3, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 4, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 4, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.